These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

297 related items for PubMed ID: 33401494

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Navigating the Solution to Drug Formulation Problems at Research and Development Stages by Amorphous Solid Dispersion Technology.
    Tripathi D, B H MP, Sahoo J, Kumari J.
    Recent Adv Drug Deliv Formul; 2024; 18(2):79-99. PubMed ID: 38062659
    [Abstract] [Full Text] [Related]

  • 3. Combining crystalline and polymeric excipients in API solid dispersions - Opportunity or risk?
    Veith H, Wiechert F, Luebbert C, Sadowski G.
    Eur J Pharm Biopharm; 2021 Jan; 158():323-335. PubMed ID: 33296719
    [Abstract] [Full Text] [Related]

  • 4. Formulation performance and processability window for manufacturing a dual-polymer amorphous solid dispersion via hot-melt extrusion and strand pelletization.
    Hörmann TR, Jäger N, Funke A, Mürb RK, Khinast JG, Paudel A.
    Int J Pharm; 2018 Dec 20; 553(1-2):408-421. PubMed ID: 30326284
    [Abstract] [Full Text] [Related]

  • 5. Molecular-Level Examination of Amorphous Solid Dispersion Dissolution.
    Faiz Afzal MA, Lehmkemper K, Sobich E, Hughes TF, Giesen DJ, Zhang T, Krauter CM, Winget P, Degenhardt M, Kyeremateng SO, Browning AR, Shelley JC.
    Mol Pharm; 2021 Nov 01; 18(11):3999-4014. PubMed ID: 34570503
    [Abstract] [Full Text] [Related]

  • 6. Physical stability of API/polymer-blend amorphous solid dispersions.
    Lehmkemper K, Kyeremateng SO, Bartels M, Degenhardt M, Sadowski G.
    Eur J Pharm Biopharm; 2018 Mar 01; 124():147-157. PubMed ID: 29269154
    [Abstract] [Full Text] [Related]

  • 7. Solvent influence on the phase behavior and glass transition of Amorphous Solid Dispersions.
    Dohrn S, Luebbert C, Lehmkemper K, Kyeremateng SO, Degenhardt M, Sadowski G.
    Eur J Pharm Biopharm; 2021 Jan 01; 158():132-142. PubMed ID: 33212185
    [Abstract] [Full Text] [Related]

  • 8. Recent Advances in Understanding the Micro- and Nanoscale Phenomena of Amorphous Solid Dispersions.
    Ricarte RG, Van Zee NJ, Li Z, Johnson LM, Lodge TP, Hillmyer MA.
    Mol Pharm; 2019 Oct 07; 16(10):4089-4103. PubMed ID: 31487183
    [Abstract] [Full Text] [Related]

  • 9. The Application of Modeling and Prediction to the Formation and Stability of Amorphous Solid Dispersions.
    DeBoyace K, Wildfong PLD.
    J Pharm Sci; 2018 Jan 07; 107(1):57-74. PubMed ID: 28389266
    [Abstract] [Full Text] [Related]

  • 10. Can Pure Predictions of Activity Coefficients from PC-SAFT Assist Drug-Polymer Compatibility Screening?
    Pavliš J, Mathers A, Fulem M, Klajmon M.
    Mol Pharm; 2023 Aug 07; 20(8):3960-3974. PubMed ID: 37386723
    [Abstract] [Full Text] [Related]

  • 11. High-throughput kinetic turbidity analysis for determination of amorphous solubility and excipient screening for amorphous solid dispersions.
    Fan Y, Castleberry S.
    Int J Pharm; 2023 Jan 25; 631():122495. PubMed ID: 36526147
    [Abstract] [Full Text] [Related]

  • 12. Mutual Impact of Phase Separation/Crystallization and Water Sorption in Amorphous Solid Dispersions.
    Luebbert C, Wessner M, Sadowski G.
    Mol Pharm; 2018 Feb 05; 15(2):669-678. PubMed ID: 29309155
    [Abstract] [Full Text] [Related]

  • 13. The influence of polymer excipients on the dissolution and recrystallization behavior of ketoconazole: Application, variation and practical aspects of a pH shift method.
    Ullrich A, Schiffter HA.
    Eur J Pharm Biopharm; 2018 Dec 05; 133():20-30. PubMed ID: 30261267
    [Abstract] [Full Text] [Related]

  • 14. Drug Release and Nanodroplet Formation from Amorphous Solid Dispersions: Insight into the Roles of Drug Physicochemical Properties and Polymer Selection.
    Yang R, Mann AKP, Van Duong T, Ormes JD, Okoh GA, Hermans A, Taylor LS.
    Mol Pharm; 2021 May 03; 18(5):2066-2081. PubMed ID: 33784104
    [Abstract] [Full Text] [Related]

  • 15. Investigation into the Solid-State Properties and Dissolution Profile of Spray-Dried Ternary Amorphous Solid Dispersions: A Rational Step toward the Design and Development of a Multicomponent Amorphous System.
    Baghel S, Cathcart H, O'Reilly NJ.
    Mol Pharm; 2018 Sep 04; 15(9):3796-3812. PubMed ID: 30020788
    [Abstract] [Full Text] [Related]

  • 16. Amorphous solid dispersion of ibuprofen: A comparative study on the effect of solution based techniques.
    Ziaee A, O'Dea S, Howard-Hildige A, Padrela L, Potter C, Iqbal J, Albadarin AB, Walker G, O'Reilly EJ.
    Int J Pharm; 2019 Dec 15; 572():118816. PubMed ID: 31678527
    [Abstract] [Full Text] [Related]

  • 17. A Mechanistic Model for Predicting the Physical Stability of Amorphous Solid Dispersions.
    Ojo AT, Lee PI.
    J Pharm Sci; 2021 Apr 15; 110(4):1495-1512. PubMed ID: 32818440
    [Abstract] [Full Text] [Related]

  • 18. Advances in Polymer Design for Enhancing Oral Drug Solubility and Delivery.
    Ting JM, Porter WW, Mecca JM, Bates FS, Reineke TM.
    Bioconjug Chem; 2018 Apr 18; 29(4):939-952. PubMed ID: 29319295
    [Abstract] [Full Text] [Related]

  • 19. Five-Stage Approach for a Systematic Screening and Development of Etravirine Amorphous Solid Dispersions by Hot-Melt Extrusion.
    Simões MF, Pereira A, Cardoso S, Cadonau S, Werner K, Pinto RMA, Simões S.
    Mol Pharm; 2020 Feb 03; 17(2):554-568. PubMed ID: 31774685
    [Abstract] [Full Text] [Related]

  • 20. Analytical and Computational Methods for the Determination of Drug-Polymer Solubility and Miscibility.
    Thakore SD, Akhtar J, Jain R, Paudel A, Bansal AK.
    Mol Pharm; 2021 Aug 02; 18(8):2835-2866. PubMed ID: 34041914
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.